Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Schizophr Res. 2012 Aug 19;141(2-3):185–188. doi: 10.1016/j.schres.2012.07.021

Table 2.

Correlations between CB1 receptor binding in the dorsolateral prefrontal cortex (DLPFC) of individuals with schizophrenia (SCZ) and controls.

SCZ
Controls
Variable R p R p
pH −0.034 0.818 0.024 0.879
PMI 0.163 0.273 0.023 0.884
BMI −0.036 0.818 0.243 0.121
Age of Onset −0.01 0.989 N.A. N.A.
Duration of Illness 0.11 0.499 N.A. N.A.
Age at Death 0.035 0.817 −0.273 0.076
Brain Weight 0.204 0.169 0.114 0.467
Freezer Storage Time 0 0.998 −0.121 0.465
Age at First Hospitalization 0.02 0.915 N.A. N.A.
Median CPZE −0.15 0.341 N.A. N.A.
Cumulative Lifetime CPZE −0.3 0.051 N.A. N.A.
Last Known CPZE −0.25 0.147 N.A. N.A.
t
p
t
p
Smoking Status 0.94 0.352 0.422 0.675
Gender 0.108 0.915 0.154 0.879
Comorbid Alcohol Abuse/ Dependence 0.28 0.780 N.A. N.A.
Comorbid Substance Abuse/ Dependence 0.47 0.642 N.A. N.A.
Antipsychotic drugs in brain at autopsy −0.46 0.646 N.A. N.A.
Nicotine in brain at autopsy −0.23 0.823 0.70 0.489
Cotinine in brain at autopsy −1.30 0.200 0.56 0.581
Gender 0.108 0.915 0.154 0.879

BMI: body mass index; CPZE: chlorpromazine equivalents; PMI: postmortem interval